Ikarian Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Hold |
163,363
| – | – | 0.26% | 49 |
|
|
2025
Q1 | $1.28M | Sell |
163,363
-215,000
| -57% | -$1.69M | 0.16% | 53 |
|
|
2024
Q4 | $5.63M | Sell |
378,363
-365,637
| -49% | -$5.44M | 0.77% | 20 |
|
|
2024
Q3 | $11.4M | Buy |
744,000
+599,000
| +413% | +$9.16M | 1.59% | 4 |
|
|
2024
Q2 | $2.21M | Buy |
+145,000
| New | +$2.21M | 0.38% | 35 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 115 |
|
|
2023
Q4 | – | Sell |
-254,876
| Closed | -$4.58M | – | 114 |
|
|
2023
Q3 | $4.58M | Sell |
254,876
-25,124
| -9% | -$451K | 0.55% | 19 |
|
|
2023
Q2 | $5.69M | Buy |
280,000
+50,000
| +22% | +$1.02M | 0.91% | 15 |
|
|
2023
Q1 | $4.2M | Buy |
230,000
+92,013
| +67% | +$1.68M | 0.95% | 22 |
|
|
2022
Q4 | $2.85M | Buy |
+137,987
| New | +$2.85M | 0.69% | 27 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 110 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 151 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 173 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 177 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 183 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 209 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 227 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 177 |
|